(NEW YORK) — Respiratory illness activity – a measure of how often conditions like the common cold, flu, COVID-19, and respiratory syncytial virus are diagnosed – is currently “high” in the United States, according to an update from the Centers for Disease Control and Prevention.
Currently, New Hampshire is listed as having “very high” respiratory virus activity, and 11 states – Arizona, Delaware, Georgia, Idaho, Kansas, Kentucky, Louisiana, Oklahoma, Tennessee, Texas and Wisconsin – are listed as having “high” activity, CDC data shows.
Meanwhile, 29 states are listed as having “moderate” activity, and the remaining states are listed as having “low” activity.
Particularly, COVID-19, seasonal flu and RSV activity are increasing across the country with a rising number of people visiting emergency departments and the number of tests coming back positive for one of the three conditions, the CDC said.
The CDC estimates that there have been at least 3.1 million illnesses, 37,000 hospitalizations and 1,500 deaths from flu so far this season; these figures are based on the latest date for which data is available, which is the week ending Dec. 21.
Five pediatric deaths were reported during the week of Dec. 21, bringing the total number to nine so far during the 2024-25 season.
The CDC says levels of the COVID-19 virus being detected in wastewater are increasing, as are the number of emergency department visits and laboratory test positivity rates.
“Based on CDC modeled estimates of epidemic growth, we predict COVID-19 illness will continue to increase in the coming weeks as it usually does in the winter,” the CDC said in a statement.
For RSV, the CDC said emergency department visits and hospitalizations are increasing among children and hospitalizations are increasing among older adults in some areas.
Flu and COVID-19 vaccines are available for both children and adults, and RSV vaccines are available for certain groups of adults. However, vaccination coverage remains low, meaning “many children and adults lack protection from respiratory virus infections provided by vaccines,” according to the CDC.
As of Dec. 21, only 41.9% of adults were vaccinated against the flu and 21.4% were vaccinated with the updated 2024-25 COVID-19 vaccine. Additionally, just 43.7% of adults ages 75 and older have received the RSV vaccine, according to CDC data.
Nearly half of all children are vaccinated against the flu at 42.5%, but just 10.3% have received the updated COVID-19 vaccine.
More than 90 norovirus outbreaks were reported during the week of Dec. 5, the most recent week for which data is available, according to the CDC.
CDC data from previous years for the same December week show a maximum of 65 outbreaks reported.
National CDC data reflects what has been reported in state and counties across the country.
In Minnesota, more than 40 outbreaks were reported in December, almost twice the usual number, according to the state Department of Health.
Earlier this month, an event celebrating the top restaurants in Los Angeles left at least 80 people sickened with norovirus, which was linked to raw oysters, the county’s Department of Public Health confirmed to ABC News.
Norovirus is a highly contagious virus that is the most common cause of viral gastroenteritis, which is an inflammation of the inside lining of the gastrointestinal tract.
Although it’s often referred to as the “stomach bug” or “stomach flu,” norovirus illness is not related to influenza.
The most common symptoms are nausea, vomiting, stomach pain and diarrhea. Patients, however, can also experience fever, headaches and body aches.
According to the federal health agency, every year the virus causes between 19 and 21 million illnesses, 109,000 hospitalizations and 900 deaths.
A person can become infected by having direct contact with someone who is infected and sharing food or utensils with them; touching surfaces or objects contaminated with norovirus and then touching their face or mouth; or consuming contaminated foods or liquids.
Typically, an infected person will develop symptoms between 12 to 48 hours after being infected. However, norovirus typically resolves quickly and, in most healthy adults, lasts one to three days, according to the CDC.
There is no specific medication or antiviral for norovirus, meaning the only treatment available is managing symptoms.
The CDC recommends staying hydrated and drinking liquids that replenish electrolytes, which can be depleted through diarrhea and vomiting.
Although symptoms will resolve in a few days for most people, certain groups are at high risk for severe dehydration including those under age 1, the elderly and the immunocompromised.
Health experts say the best way to prevent getting norovirus is to wash hands with warm soap and water for 20 seconds. Hand sanitizer does not work well against norovirus.
The CDC says people should wash their hands after using the toilet or changing diapers as well as when eating, preparing or handling food.
To prevent contamination from food, make sure fruits and vegetables are washed, and that shellfish is cooked to at least an internal temperature of 145 F.
(NEW YORK) — Three states — Louisiana, Kentucky and New Hampshire — are reporting high levels of respiratory illness, including common cold, flu, RSV and COVID, according to the CDC. In addition, children under four are currently experiencing the highest levels of RSV hospitalizations.
Dr. Neil C. Bhavsar, an emergency medicine resident at New York-Presbyterian Hospital and a member of the ABC News Medical Unit, said that those illnesses come out “roaring” at this time of year because people are staying indoors, coming from all over and spending time with family.
He wants people to know the severity of their illness and where to go so it’s best treated, he said.
“Urgent Care is a quick fix,” Bhavsar said. Typically, it’s best for non-life-threatening conditions that are addressed within 30 minutes to a few hours.
“The ER or the emergency department is for serious injuries, life-threatening illness or something that can become very serious,” he said.
He explains that respiratory illnesses may take a few days to figure out.
“When we’re talking about respiratory illnesses, I would say, if you’re not feeling too well for like two to three days, have a low grade fever, a cough that’s been lingering for a little bit longer than you want, some facial pressure, sinus pressure, congestion, urgent care is your friend,” Bhavsar said.
But he warns that if “your fingertips are blue, your lips are blue, you’re feeling short of breath and you have chest pain” to go to the emergency department. Any child with these symptoms, especially trouble breathing, should be evaluated in an emergency room.
For upper respiratory illnesses, Bhavsar urges people to stay hydrated.
“Drink warm fluids, soup, broths, hot teas, you can try a nasal spray for congestion and honey is a big thing we’ve been doing for a sore throat or a cough,” Bhavsar said. But he warns honey should never be given to infants or anyone less than a year old due to the risk of a severe illness called botulism.
He also recommends steam inhalation and over-the-counter decongestants for respiratory illnesses, but these should not be used for more than 3-5 days in a row.
In addition, Bhavsar said ibuprofen or acetaminophen can help with body aches and chills. Always follow dosing instructions, ages for use, and consult with a physician if uncertain on how to take any these medications.
Los Angeles County health officials reported the first human case of bird flu in the area less than a week after a statewide emergency declaration was announced.
In a statement released on Monday, the L.A. County Department of Public Health said the human case of H5 bird flu was detected in an adult who was exposed to livestock infected with the virus at a worksite.
The unnamed adult had mild symptoms, has been treated with antivirals and is recovering at home, according to the agency.
“The overall risk of H5 bird flu to the public remains low,” health officials said.
There are at least 65 confirmed human cases of bird flu nationally — with at least 36 in California, according to the CDC.
California Gov. Gavin Newsom declared a state of emergency on Dec. 18 as bird flu cases were detected in dairy cows on Southern California farms. The virus had also been previously detected in the state’s Central Valley.
“This proclamation is a targeted action to ensure government agencies have the resources and flexibility they need to respond quickly to this outbreak,” Newsom said in a statement last week.
Symptoms of bird flu in humans include eye redness or discharge, fever, cough or difficulty breathing, sore throat, muscle or body aches, diarrhea and vomiting, according to health officials.
Individuals working with infected animals, including cows, poultry or wildlife, continue to be at higher risk of exposure to the virus.
“People rarely get bird flu, but those who interact with infected livestock or wildlife have a greater risk of infection. This case reminds us to take basic precautions to prevent being exposed,” Los Angeles County health officer Muntu Davis, MD, MPH, said in the statement Monday.
“People should avoid unprotected contact with sick or dead animals including cows, poultry, and wild birds; avoid consuming raw or undercooked animal products, such as raw milk; and protect pets and backyard poultry from exposure to wild animals,” Davis added.
The health official also recommended getting the seasonal flu vaccine “which can help prevent severe seasonal flu illness and lower the risk of getting both seasonal and bird flu infections at the same time if exposed.”
(NEW YORK) — From a pig kidney transplant to restoring genetic deafness, 2024 was a year full of medical breakthroughs.
The breakthroughs include the discovery of a cause of an autoimmune disease, the development of a “game-changing” drug and potential hope for those experiencing end-stage organ failure.
Here are five of the biggest highlights in medical achievements this year:
Gene therapy restores hearing in children
Children with hereditary deafness regained their hearing thanks to a type of gene therapy, according to the results of a clinical trial published in the medical journal The Lancet in January.
Investigators from Mass Eye and Ear, a specialty hospital in Boston, examined six children who had a form of genetic deafness called DFNB9, which is caused by a gene mutation that interferes with the transmission of sound signals from the ear to the brain.
Gene therapy involved the use of an inactive virus carrying a functioning version of the gene, which was introduced into the inner ears of the six children.
After 26 weeks, five of the six children recovered their hearing and could even conduct “normal conversation.”
“Children with this genetic hearing loss…the only treatment option for them until now is [a] cochlear implant,” Dr. Zheng-Yi Chen, an associate scientist in the Eaton-Peabody Laboratories at Mass Eye and Ear and study co-investigator, told ABC News. “And of course, [a] cochlear implant can help them tremendously, but it’s with its own limitations.”
“But with this gene therapy, the children regain hearing, and they were able to speak. So, in a way, the life is totally transformed,” he continued. “This study really opened up the whole field that, in the future, we’ll be able to develop a treatment for other [types] of genetic hearing loss, for which there is no treatment at all at the moment.”
Groundbreaking animal organ transplant
Surgeons at Massachusetts General Hospital (MGH) conducted the world’s first genetically-edited pig kidney transplant into a living human in March 2024.
During a four-hour procedure, a surgical team connected the pig kidney’s blood vessels and ureter – the duct that carries urine from the kidney to the bladder – with those of 62-year-old Richard Slayman, a man living with end-stage kidney disease.
“For patients with kidney failure, we know that transplantation is the best treatment option, but unfortunately, we face an immense organ shortage,” Dr. Leonardo Riella, medical director of kidney transplantation at MGH, told ABC News. “So, we have over 100,000 patients waiting for a kidney transplant in the U.S., and more than 17 patients die every day on the waiting list.”
“So, the idea here is, how can we overcome this organ shortage barrier? And having kidneys from another species that could be delivered in a timely manner for these patients once they develop kidney failure could be game-changing for the entire field,” he added.
Slayman passed away in May of this year, but there is no evidence it was the result of the transplant, according to MGH.
Riella said over the course of Slayman’s care, much was learned about how to best deliver care when using animal organs for transplants in the hopes of making the treatment more widely available to patients waiting for a new organ.
A cause of lupus discovered
A team at Brigham & Women’s Hospital and Northwestern Medicine said they have discovered a cause of the autoimmune disease lupus and a possible way to reverse it.
Lupus sees the body’s immune system mistakenly attack its own healthy cells and tissues, which can cause inflammation and damage in organs or systems, according to the Centers for Disease Control and Prevention.
In a study, published in the journal Nature in July, researchers compared blood samples from 19 lupus patients to 19 patients without the condition and found imbalances in the types of T-cells lupus patients produce.
T-cells are a certain type of white blood cell that plays a crucial role in the body’s immune response to the disease.
“We’ve identified a fundamental imbalance in the immune responses that patients with lupus make, and we’ve defined specific mediators that can correct this imbalance to dampen the pathologic autoimmune response,” co-corresponding author Dr. Deepak Rao, a rheumatologist at Brigham and Women’s Hospital and co-director of its Center for Cellular Profiling, said in a press release at the time.
1st new class of schizophrenia drug in more than 3 decades
In September, the FDA approved the first new class of drug to treat people with schizophrenia in more than 30 years.
The pill, called Cobenfy – manufactured by Bristol Myers Squibb – combines two drugs, xanomeline and trospium chloride, and is taken twice a day.
Clinical trials showed the combination helped manage schizophrenia symptoms such as hallucinations, delusions and disorganized thinking.
Dr. René Kahn, chair of psychiatry at the Icahn School of Medicine at Mount Sinai, said it took many years to develop the first medications for schizophrenia, which are effective in preventing psychosis and work by blocking dopamine receptors.
“Blocking the dopamine receptor directly or indirectly is very unpleasant. Sometimes for patients, they can have unpleasant side effects. It can decrease their energy, it can make them feel depressed, and it can give them Parkinsonian side effects,” Kahn told ABC News.
He described Cobenfy as “game-changing in the sense that this is the first drug that doesn’t directly – with the emphasis on directly – influence the dopamine system and certainly doesn’t block dopamine receptors. So that’s very important, because it may show that we don’t have to directly block or affect the dopamine system but can do that through a different mechanism.”
Kahn said the next step will be monitoring the drug as it is prescribed to thousands of schizophrenia patients to ensure it works and that side effects are minimal.
1st over-the-counter combo flu and COVID test outside of emergency use
The FDA authorized the first over-the-counter combination COVID-19 and flu test outside of emergency use in October.
The Healgen Rapid Check COVID-19/Flu A&B Antigen Test can be purchased at a pharmacy or other stores without a prescription.
While there are other over-the-counter combination tests currently available, this is the first to be marketed to consumers using the traditional approval pathway outside of a public health emergency, according to the FDA.
(NEW YORK) — The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity — the first medication approved for the condition.
The new, expanded Zepbound approval means that insurance providers, including Medicare, will likely cover the medication for people with sleep apnea and obesity. Some insurance providers, including Medicare, do not offer reimbursement to treat obesity alone.
The new approval is for people with moderate to severe obstructive sleep apnea who are also living with obesity. Eli Lilly estimates that is about 15-20 million adults in the U.S.
Obstructive sleep apnea isn’t just an inconvenience, it’s a serious medical condition that impairs breathing and sleep quality. Obesity and obstructive sleep apnea are linked. People tend to see their obstructive sleep apnea get better when they lose a significant amount of weight. It’s likely the weight loss associated with the medication is helping improve the sleep apnea.
Right now, there is no medicine to treat obstructive sleep apnea — it’s only treated with a positive airway pressure device.
In a study, people who took Zepbound had at least 25 fewer breathing interruptions per hour while they slept. They also lost an average of 20% of their body weight.
The study also followed people over a year, and found that up to half of the adults taking Zepbound no longer had obstructive sleep apnea symptoms at the end of the year.
Obstructive sleep apnea is more common in men than women. Up to 34% of U.S. men have OSA compared to 17% of U.S. women, according to the American Academy of Family Physicians.
Common signs of sleep apnea include heavy snoring at night, long pauses in breathing while sleeping as well as excessive daytime sleepiness, forgetfulness and morning headaches. The symptoms of the disorder can lead to significant medical problems.
Jessie Owen was left paralyzed nearly 12 years ago when a tree fell on a car in which she was a passenger. Via ABC News.
(NEW YORK) — Nearly 12 years ago, Jessie Owen’s life changed forever.
“My family was going over a mountain pass and a tree fell on our car. In that moment, my parents passed away, my siblings were severely injured, and I became quadriplegic,” Owen said. “I lost my independence. I lost my job. I lost my apartment. I lost my autonomy and the life that I dreamed for myself.”
Like Owen, more than 300,000 people live with spinal cord injuries in the United States, with an estimated 18,000 new cases each year, data shows.
Motor vehicle accidents account for the majority of spinal cord injuries and are closely followed by falls, acts of violence and sports activities, according to the National Spinal Cord Injury Statistical Center.
For years, options for recovery have been limited, but a newly FDA-cleared external spinal stimulator, ARC-EX Therapy, which received clearance on Dec. 19, may offer hope for people like Owen.
“ARC-EX is simply electrodes attached to skin on the back of the neck,” explained Chet Moritz, M.D., a professor of rehabilitation medicine at the University of Washington. “It allows us to pass current through the skin to activate the sensory nerves as they enter the spinal cord. Now, those sensory nerves make direct connections to the motor nerves which help people to move.”
Owen, who participated in the Up-LIFT study, a clinical trial focusing on the health benefits of ARC-EX Therapy, saw a life-changing impact.
“I was wildly surprised and pleased to see that it was making meaningful change in my life. I can now paint with my hands. I can open a jar of peanut butter. I can tie my shoes. It [used to] take me 30 minutes to get dressed. Now it takes 12. [I used to require] 20 caregiving hours a week and I was able to move down to about eight.”
The Up-LIFT study produced promising results.
Of the 60 patients with cervical spinal cord injuries studied, 72% saw improvements in hand strength and function. Participants also reported fewer muscle spasms, better sleep, less pain, and improved independence during daily activities.
“The success of [this] study of people with spinal cord injuries is phenomenal,” noted Moritz. “There are essentially no current therapies for chronic spinal cord injury, and so having the majority of patients respond in both strength and function measures [is] just an outstanding result.”
With FDA approval, ARC-EX Therapy is expected to become more accessible.
“Patients can work with their local rehabilitation clinics to see a therapist and work with them in the clinic at first to tune the device,” Moritz said. Results may appear quickly — some participants noticed changes within just a few sessions, he added.
While the device is currently cleared for improving hand strength, function and sensation, Moritz noted other benefits: “Some people will have modest improvements in their bladder function, heart rate, or blood pressure control.”
Leah Croll, M.D., vascular neurologist at Maimonides Health and assistant professor of neurology at SUNY Downstate, shared the excitement over the device.
“The idea that ARC-EX Therapy may accelerate or augment neurologic recovery is really exciting. Any improvement in neurologic function is meaningful and has far-reaching impact in the daily lives of these patients and their families,” she said.
The road to recovery after a spinal cord injury is grueling, Croll said.
“After emergency and ICU care is completed, the mainstay of treatment is working closely with physical therapists, occupational therapists and other rehabilitation professionals to support neurologic recovery,” said Croll. “Patients may also need medications and certain procedures, depending on their unique symptoms.”
For Owen and others, ARC-EX Therapy represents a renewed sense of hope and an exciting change in the way these patients can be treated.
“[With ARC-EX Therapy], I continued to gain function back, and I found I was able to pour more into other people,” Owen said. “The first indicator of success that I noticed was my own happiness. It works, and it gives us hope and passion.”
Natalie S. Rosen, M.D., is a physician in the Hematology & Oncology Department at New York-Presbyterian Columbia and a member of the ABC News Medical Unit.
(NEW YORK) — A deadly, undiagnosed disease that has been spreading in one region of the Democratic Republic of Congo (DRC) may be linked to malaria, health officials said Thursday.
As of Dec. 14, the latest date for which data is available, 592 cases have been reported with 37 confirmed deaths and 44 deaths under investigation, according to the Africa Centres for Disease Control and Prevention (Africa CDC), the public health agency of the African Union.
Over the last week, 181 samples from 51 cases were tested in a laboratory, Dr. Ngashi Ngongo, Africa CDC chief of staff, said during a Thursday press briefing.
Laboratory testing showed 25 out of 29 tested were positive for malaria. Additionally, rapid testing showed 55 out of 88 patients were positive for malaria.
Ngashi said there are two hypotheses: The first is that the undiagnosed disease is severe malaria “on a background of malnutrition and viral infection” and the second is the disease is a viral infection “on a background of malaria and malnutrition.”
Malaria is a serious disease caused by a parasite that infects a certain type of mosquito, according to the U.S. Centers for Disease Control and Prevention (CDC). Most people contract malaria after being bitten by an infected mosquito.
Most cases of malaria occur in sub-Saharan Africa, but it also occurs in parts of Oceania and in parts of Central and South America and Southeast Asia.
Malaria can be deadly if is not diagnosed and treated quickly, the CDC said.
What we know about the disease
The disease first appeared in a remote area in the province of Kwango, in the southwestern part of the DRC on the border with Angola, according to Africa CDC.
The first case was documented on Oct. 24. Patients have been experiencing flu-like symptoms including fever, headache, coughing and difficulty breathing as well as anemia, Africa CDC said during a press briefing earlier this month.
A plurality of cases, or 42.7%, have occurred in children under 5 years old. This age group also has the largest number of deaths, with 21 so far, data from Africa CDC shows. Children between ages 5 and 9 make up the second highest number of cases
Africa CDC said in a post on X earlier this month that it took five to six weeks after the first case was reported for local authorities to alert the national government, highlighting “gaps in Africa’s disease detection systems: limited surveillance, testing delays & weak lab infrastructure.”
-ABC News’ Youri Benadjaoud contributed to this report.
(NEW YORK) — The Centers for Disease Control and Prevention has confirmed the first case of severe bird flu in the United States.
The federal health agency said Wednesday that the patient has been hospitalized in Louisiana. No identifying details about the patient were made available.
Genomic data showed the Louisiana patient was infected with a version of the virus recently found to be spreading in wild birds and poultry in the U.S., as well as found in some human cases in Canada and Washington state, according to the CDC.
This is different than the version of the virus found to be spreading in dairy cows and poultry populations in the U.S.
The Louisiana patient was exposed to sick and dead birds in backyard flocks, although an investigation into the source of the illness is ongoing, the CDC said. This is the first case of human bird flu in the U.S. linked to exposure to backyard flock.
There have been 61 reported human cases of bird flu reported in the U.S. since April.
This is a developing story. Please check back for updates.
(NEW YORK) — Authorities are looking into online accounts believed to be those of Luigi Mangione, the 26-year-old Ivy League graduate charged with murder in the fatal shooting of UnitedHealthcare CEO Brian Thompson on a Manhattan street, that have posted about health struggles and possible medical successes.
Mangione appeared to operate a Reddit profile where he detailed health issues including back pain, brain fog and sciatica. The account made several posts on a subreddit dedicated to spondylolisthesis — a condition where a vertebra slips out of alignment. Mangione also might have planned to read or already read multiple books on back pain based on a Goodreads account associated with him.
Law enforcement sources have told ABC News that the Reddit profile — which has since been taken down — is being reviewed for additional details about the extent of the injuries mentioned. A Reddit spokesperson told ABC News regarding the page that their policy is to suspend accounts that may potentially be related to suspects in high-profile criminal investigations.
Mangione is accused of gunning down Thompson outside a Midtown Manhattan hotel on Dec. 4. Written on the shell casings were the words “deny,” “defend” and “depose,” according to police sources. Mangione was apprehended in Altoona, Pennsylvania, on Monday after nearly one week on the run. He allegedly had a spiral notebook detailing plans about how to eventually kill the CEO, according to law enforcement officials.
Mangione is being held without bail in Pennsylvania, where he faces charges including allegedly possessing an untraceable ghost gun. Defense attorney Thomas Dickey told reporters on Tuesday that Mangione will plead not guilty to the Pennsylvania charges. He said he anticipates that Mangione will also plead not guilty to the second-degree murder charge in New York.
The posts and reading lists paint a picture of someone seeking answers, sharing how spinal fusion surgery brought the author relief after years of discomfort.
“Chronic pain can be incredibly debilitating. It can affect every aspect of your life,” Dr. Joseph Shrand, chief medical officer of Riverside Community Care in Massachusetts and a Harvard Medical School faculty member, told ABC News.
While the Reddit posts suggest a spinal surgery was a significant moment in his life, the author of the posts said the procedure left him pain-free, and he frequently encouraged others to undertake similar procedures.
In an August 2023 post, the user remarked how his spinal injury was once “completely devastating” and worried he was “destined to chronic pain and a desk job for the rest of my life” before considering surgery.
Chronic pain, defined as pain lasting three months or more, affects about 50 million U.S. adults, according to the National Institutes of Health. Of these, 17 million Americans experience “high impact” chronic pain, which is so debilitating that it disrupts daily activities like work, self-care and relationships, the NIH says.
Women, older adults, and those living in poverty or rural areas tend to report the highest rates of persistent pain. So do people who are divorced or separated, identify as bisexual, or say they are generally in poor health, according to the NIH.
Studies suggest that chronic pain can put people at a higher risk of mental health struggles, as well as create a financial burden.
Research shows that between 35% to 45% of those with chronic pain experience depression, while anxiety disorders are similarly common. Pain may interfere with sleep, increase stress, and create cycles of declining mental and physical health.
“Chronic pain puts you at a disadvantage mentally because you may think other people see you as broken,” Shrand said. “There will be times where you may feel in such physical pain that it becomes emotional pain, too.”
Some studies suggest a biological link between chronic pain and mental health disorders. For example, depression can heighten pain sensitivity, reinforcing the connection between the two, according to a study in the journal Neural Plasticity.
Chronic pain affects every facet of life. It can limit employment opportunities, disrupt social connections and lead to cognitive challenges, including “brain fog.”
“People have difficulty getting out of bed in the morning because their backs hurt, which means that they’re potentially at risk of coming into work late, which then puts them at risk for the cascade effects of all those things that can happen because they are now perceived as a person who isn’t doing their job right,” Shrand said.
Chronic pain can lead to a substantial financial burden, as well. According to one Journal of Pain study, individuals with severe pain spend more than $4,000 more annually on health care versus those without pain.
Managing chronic pain requires a combination of medical, psychological and lifestyle interventions, but insurance often prioritizes medications and procedures with inconsistent results.
For instance, lumbar fusion surgeries — such as the one purportedly described by Mangione — are commonly performed but often fail to provide lasting relief, according to various studies.
When Mangione was arrested on Monday, he had “written admissions about the crime” with him, according to the New York arrest warrant.
Mangione had several handwritten pages on him that expressed a “disdain for corporate America” and indicated “he’s frustrated with the health care system in the United States,” NYPD Chief of Detectives Joe Kenny told ABC News’ “Good Morning America” on Tuesday.
The words on the bullets echo the title of the 2010 book “Delay, Deny, Defend: Why Insurance Companies Don’t Pay Claims and What You Can Do About It.” Police are aware of the similarity, and are investigating whether one possible motive is anger at the insurance industry, sources said.
While the Reddit posts suggest a spinal surgery was a significant moment in his life, the author of the posts said the procedure left him pain-free, and he frequently encouraged others to undertake similar procedures.
One of Mangione’s apparent posts on the r/Spondylolisthesis subreddit in February 2024 referred to having had a surgery for the condition six months prior. The author said that “[w]within 7 days of the fusion I was on zero pain meds.”
Many widely used approaches, such as opioids or steroid injections, provide only temporary solutions to chronic pain. Meanwhile, treatments like cognitive behavioral therapy, yoga and acceptance therapy show promise but remain difficult to access due to cost and insurance coverage gaps.
However, many chronic pain patients face a maze of treatments that don’t fully address their needs or the root causes of their pain.
Shrand said the best approach often requires a combination of solutions.
“You can’t just attack the physical. You’ve got to address the biological, mental and social aspects of life,” he said. “You can manage this pain — it’s part of your body, and we can find a way to take care of you.”
ABC News’ Peter Charalambous, Aaron Katersky, Kerem Inal, Chris Looft and Sasha Pezenik contributed to this report.
